Here's a look at some of the top Wall Street stories for medical device companies this week: Asante Solutions sets IPO terms; Stryker CEO Lobo: M&A is our top priority for cash; Abiomed surges on Q3 numbers, FDA nod; Credit agencies lower Medtronic's rating post-Covidien merger
Diabetes: Asante Solutions sets IPO terms
January 23, 2015 by Brad Perriello
Asante Solutions, Covidien, Fitch Ratings, Medtronic, Moody's Investor Service, Standard & Poor's, Stryker, Abiomed Inc.
from MassDevice - FDA and Medical device business news and jobs for the medical device industry http://ift.tt/1v9tKxs
Cap comentari:
Publica un comentari a l'entrada